Hamideh Sadat Moayedpardazi

Hamideh Moayedpardazi practices at De La Pena Eye Clinic, a Medical Group in Palm Springs, California.

Hamideh Moayedpardazi's NPI, 1386933240, was assigned on March 31, 2011. Hamideh Moayedpardazi graduated from Icahn School Of Medicine At Mount Sinai in 2011. Hamideh Moayedpardazi holds California license A137200.

Hamideh Moayedpardazi's primary practice is De La Pena Eye Clinic, a Medical Group, at 1100 N Palm Canyon Dr, Palm Springs, CA 92262 in Riverside County. The practice phone is (818) 988-1111.

Hamideh Moayedpardazi's primary practice is De La Pena Eye Clinic, a Medical Group in Palm Springs, California. The medical group on file is Greater Modesto Medical Surgical Associates. Dmand AI also links Hamideh Moayedpardazi to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hamideh Moayedpardazi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Hamideh Moayedpardazi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Hamideh Moayedpardazi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Hamideh Moayedpardazi's licenses on file in 2 states: California and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Hamideh Moayedpardazi treats.

CMS data shows 6,423 Medicare services from Hamideh Moayedpardazi across 18 procedure codes in 2024, for 953 Medicare patients. Medicare paid $289,022 for them.

CMS counts 953 Medicare patients who saw Hamideh Moayedpardazi in 2024. The largest group is 65 to 74, with 481 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 98% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hamideh Moayedpardazi's median patient age at 65, with 60% women.

In 2024, Hamideh Moayedpardazi wrote 15,998 Medicare Part D claims for 1,912 patients. 44% of them were for generic drugs. CMS names the drug for 15,886 of them, across 32 drugs with 11 or more claims each, at $3,540,232 in total drug cost. In 2023, CMS named 16,110 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Hamideh Moayedpardazi for performance year 2024, reported individually. Hamideh Moayedpardazi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 78 procedures of cataract surgery by Hamideh Moayedpardazi, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Hamideh Moayedpardazi in 2017. Hamideh Moayedpardazi's most frequent co-authors are Steven Matthew Naids, MD, Edward L. Raab, MD and Viviane S. Tabar, MD.

CMS Open Payments shows 188 general payments to Hamideh Moayedpardazi from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 93% of the total. Glaukos Corporation paid the most, $3,143.

Hamideh Moayedpardazi graduated from Icahn School Of Medicine At Mount Sinai in 2011.

Hamideh Moayedpardazi is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.